MSF Access Campaign

CHA

Tag: MSF Access Campaign

MSF: Any future COVID-19 vaccines must be sold at cost and accessible to all

Governments must attach strings as they pledge billions to pay for vaccines in developing countries Geneva — Doctors Without Borders/Médecins Sans Frontières (MSF) urged leaders to demand pharmaceutical corporations commit to selling any potential future COVID-19 vaccines at cost, as...

Read more

Access to medicines: MSF demands review of USTR Special 301 report on trade barriers

In a letter to the United States Trade Representative (USTR) on 6th February 2020, Médecins Sans Frontières (MSF)/Doctors Without Borders submitted comments to the review process of USTR’s 2020 Special 301 Report and raised concerns of the public health impact of...

Read more

MSF: Global vaccines community must urgently support roll out of new more affordable pneumonia vaccine

Global vaccines community must do everything it can to help introduce the new, more affordable pneumonia vaccine in all countries, especially middle-income countries Barcelona – As governments and the global vaccines community gather this week at the first ever Global...

Read more

Access to medicines: As J&J release earnings, MSF protests price of lifesaving TB drug

As J&J release earnings, MSF protests price of lifesaving TB drug in front of New York Stock Exchange New York, 22 January 2020—Médecins Sans Frontières (MSF) protested in front of the New York Stock Exchange in New York today, demanding...

Read more

Access to medicines: Gavi must ensure more children get new, more affordable pneumonia vaccine

Geneva, 21 January 2020 — As Gavi, the Vaccine Alliance, starts to commemorate its 20th year and launches a new fundraising appeal, the international medical humanitarian organisation Doctors Without Borders/Médecins Sans Frontières (MSF) stressed that more must be done to...

Read more

MSF and TB activists disrupt opening of TB conference to protest drug corporations keeping life-saving medicines from people

Newer medicines for DR-TB are desperately needed, but barriers to access, including high prices, keep them out of reach for most people around the world. Hyderabad, 30 October – Doctors Without Borders/Médecins Sans Frontières (MSF) joined tuberculosis (TB) activists to disrupt...

Read more

Access to medicines: MSF demands Johnson & Johnson reduce price of lifesaving TB drug

GENEVA - Doctors Without Borders/Médecins Sans Frontières (MSF) has launched a global campaign calling on pharmaceutical corporation Johnson & Johnson (J&J) to lower the price of its anti-tuberculosis medicine bedaquiline to no more than US$1 per day for people everywhere who...

Read more

MSF urges PM Modi not to make any trade commitments to US threatening access to medicines

Ahead of the Prime Minister Narendra Modi’s visit to the US to discuss a ‘trade-package’ with the US President Donald Trump, Médecins Sans Frontières/ Doctors Without Borders (MSF) urges the Indian government to not make any commitments regarding intellectual property,...

Read more

MSF: U.S. Special 301 report undermines efforts to lower medicine prices globally

On the eve of World Intellectual Property Day, the United States Trade Representative released its annual “Special 301 Report.” Developing countries like India and Malaysia once again face unfair pressure from the US government over the measures these countries have...

Read more

Tuberculosis: TB activists challenge Johnson & Johnson patent application on bedaquiline in India

Mumbai/Cape Town - Doctors Without Borders/Médecins Sans Frontières (MSF) is supporting a patent challenge filed in India this week by two tuberculosis survivors, to prevent pharmaceutical corporation Johnson & Johnson (J&J) from extending its monopoly on the tuberculosis drug bedaquiline. Nandita...

Read more

Tuberculosis: TB activists challenge Johnson & Johnson patent application on bedaquiline in India

Mumbai/Cape Town - Doctors Without Borders/Médecins Sans Frontières (MSF) is supporting a patent challenge filed in India this week by two tuberculosis survivors, to prevent pharmaceutical corporation Johnson & Johnson (J&J) from extending its monopoly on the tuberculosis drug bedaquiline....

Read more

Access to medicines

Unaffordable, unavailable, not adapted - people around the world face these challenges in accessing lifesaving medicines. During the 1990s, MSF teams made a bitter observation: we were failing to treat some of our patients suffering from infectious diseases, while in...

Read more
Show Buttons
Share On Facebook
Share On Twitter
Share On Linkedin
Contact us
Hide Buttons